MuBC has a higher positivity rate for hormone receptors (HR), less lymph node metastasis, lower anatomical stage, and less human epidermal growth factor receptor 2 (HER-2) overexpression than invasive ductal carcinoma (IDC) [5]. Here, ERBB2 is linked to invasive ductal breast carcinoma.